Our Progress

 Our dream at Sanguis is to revolutionize the care of cancer patients with a simple but powerful technology. We are thankful to our various collaborators and funding sources, who have helped us put together a strong initial product.

Accomplishments

WTH Innovation Fund Winner

Our team won the Weiss Tech House Innovation Fund in Fall 2016

Wharton Entrepreneurship Fund Winner

We were the 2016 Winners of the Wharton Innovation Fund, and were accepted to the Wharton Venture Initiation Program-Community 

Science Center Phase 1 Ventures Winner

Accepted to the Spring 2017 Cohort of Philadelphia University City Science CEnter's P1V program

PennApps Accelerator Winner

Participants in the Fall 2016 PennApps Accelerator

Port Incubator: Spring 2017 Class

We were honored to be accepted to the Port Incubator Program and subsequently described by the Philadelphia Business Journal as breakthrough startup working to improve cancer treatment.

Technical.ly Philly: Startup to Watch Out For

Technical.ly Media Listed Sanguis as 1 of 4 Philadelphia startups to watch out for in 2017. 

Penn I-Corps Winner

Sanguis was selected as an I-corps winner during the program's Fall 2016 cycle. We are thankful to Penn I-corps for their support of our customer discovery activities.

Innovation Seed Grant Winner

Winners of the 2017 "Big Ideas Through Small Technology" Grant and recognized as the Philadelphia area’s brightest minds to prototype innovative technology through the usage of nanotechnology.

Philadelphia Alliance for Capital & Technologies

Sanguis became a member of PACT in Summer 2017, and aims to drive innovation and entrepreneurship in the region.

Health-X Venture Fund Winner

Sanguis was chosen as a Penn Health-X Venture Fund Recipient in 2017.